Currently out of the existing stock ratings of Leonid Timashev, 217 are a BUY (91.56%), 20 are a HOLD (8.44%).

Leonid Timashev

Work Performance Price Targets & Ratings Chart

Analyst Leonid Timashev, currently employed at RBC, carries an average stock price target met ratio of 36.5% that have a potential upside of 37.16% achieved within 108 days. Previously, Leonid Timashev worked at JEFFERIES.

Leonid Timashev’s has documented 468 price targets and ratings displayed on 25 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VSTM, Verastem at 14-Oct-2026.

Wall Street Analyst Leonid Timashev

Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for DSGN (DESIGN THERAPEUTICS) at 3/11/2025. The price target of $5 was fulfilled within 1 day with a profit of $0.33 (6.19%) receiving and performance score of 61.91.

Average potential price target upside

RVMD Revolution Medicines EWTX Edgewise Therapeutics INSM Insmed ALKS Alkermes Plc AXSM Axsome Therapeutics BCYC Bicycle Therapeutics Ltd BHVN Biohaven Pharmaceutical Holding Co Ltd CGON CG Oncology CMPS Compass Pathways Plc CRMD CorMedix CYTK Cytokinetics DSGN Design Therapeutics EXEL Exelixis IDYA Ideaya Biosciences JAZZ Jazz Pharmaceuticals PLC LEGN Legend Biotech Corp NAMS NewAmsterdam Pharma Company N.V. NUVB Nuvation Bio PYXS Pyxis Oncology VSTM Verastem XNCR Xencor ADCT ADC Therapeutics SA BRCC BRC PRAX Praxis Precision Medicines CATX Perspective Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Jun-2026

$241

$58.85 (32.31%)

$240

Buy Since 13-Dec-2022

$275

$92.85 (50.97%)

$275

8 days ago
(14-Oct-2026)

28/33 (84.85%)

$85.74 (45.30%)

184

Buy Since 02-Nov-2025

$260

$77.85 (42.74%)

$259

9 days ago
(13-Oct-2026)

8/11 (72.73%)

$66.48 (34.35%)

31

Buy Since 14-Jul-2025

$267

$84.85 (46.58%)

$73

29 days ago
(23-Sep-2026)

2/3 (66.67%)

$67.14 (33.59%)

97

Buy Since 15-Jul-2024

$265

$82.85 (45.48%)

$170

1 months 2 days ago
(20-Sep-2026)

6/7 (85.71%)

$72.24 (37.48%)

68

Show more analysts

Please expand the browser size to see the chart

Which stock is Leonid Timashev most bullish on?

Potential upside of $220.24 has been obtained for PRAX (PRAXIS PRECISION MEDICINES)

Which stock is Leonid Timashev most reserved on?

Potential downside of -$11.23 has been obtained for EXEL (EXELIXIS)

What Year was the first public recommendation made by Leonid Timashev?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?